Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2019 | Percentile | Sector n |
|---|---|---|---|---|
| NNC | Healthcare Services | 13.9% | 49th pct | 241 |
| Alliance Med Service | Healthcare Services | -8.7% | 8th pct | 241 |
| Universaluri Sameditsin… | Healthcare Services | -12.9% | 7th pct | 241 |
| Tbilisi City Medical | Healthcare Services | -63.1% | 2nd pct | 241 |
| Akhali Sameditsino Tsen… | Healthcare Services | -106.4% | 2nd pct | 241 |
Percentile is within each company's own sector across the whole FY2019 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2019 | Universaluri Sameditsin… | Tbilisi City Medical | NNC | Alliance Med Service | Akhali Sameditsino Tsen… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 90.7% | 20.9% | 74.5% | 100.0% | 100.0% |
| EBITDA Margin | -12.9% | -63.1% | 13.9% | -8.7% | -106.4% |
| EBITDAR | -435 | -1,396 | 148 | -18 | -57 |
| EBITDAR Margin | -12.9% | -63.1% | 13.9% | -8.7% | -106.4% |
| EBIT Margin | -24.0% | -76.1% | 10.0% | -9.6% | -106.7% |
| Net Profit Margin | -24.0% | -148.1% | 9.6% | -8.8% | -84.3% |
| Operating Expense % of Sales | 103.5% | 84.0% | 60.6% | 108.7% | 206.4% |
| Returns | |||||
| Return on Assets (ROA) | -8.6% | -114.9% | 6.4% | -0.3% | -3.0% |
| Return on Equity (ROE) | -11.4% | N/A | 8.6% | -0.3% | -3.1% |
| ROIC [EBIT / Invested Capital] |
| -11.5% |
| -89.4% |
| 8.6% |
| -0.3% |
| -4.0% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | 81.7% | 3.5% | 0.5% | 0.0% |
| Debt-to-Equity | 0.00x | -6.35x | 0.05x | 0.01x | 0.00x |
| Debt-to-EBITDA | N/A | N/A | 0.38x | N/A | N/A |
| Equity-to-Assets | 75.6% | -12.9% | 74.3% | 98.1% | 94.9% |
| Net Debt | -47 | 2,251 | 53 | 28 | -0 |
| Cash & Equivalents | 47 | 81 | 3 | 6 | 0 |
| Total Debt | N/A | 2,332 | 56 | 34 | N/A |
| Liquidity & working capital | |||||
| Current Ratio | 0.22x | 0.00x | 1.03x | 7.56x | 4.16x |
| Quick Ratio | 0.18x | -0.04x | 0.93x | 7.56x | 4.16x |
| Cash Ratio | 0.03x | 0.03x | 0.01x | 0.06x | 0.00x |
| Total Current Assets | 421 | 0 | 420 | 680 | 250 |
| Total Current Liabilities | 1,877 | 3,221 | 408 | 90 | 60 |
| Inventory | 88 | 135 | 41 | N/A | N/A |
| Trade Receivables | 286 | 806 | 379 | 251 | 243 |
| Trade Payables | 647 | N/A | 251 | 90 | 60 |
| Net Working Capital | -1,456 | -3,221 | 12 | 590 | 190 |
| Net Working Capital % of Revenue | -43.1% | -145.4% | 1.2% | 286.4% | 356.3% |
| Trade Working Capital | -273 | 941 | 169 | 161 | 182 |
| Trade Working Capital % of Revenue | -8.1% | 42.5% | 16.0% | 78.2% | 342.0% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | 3.59x | 12.95x | 6.63x | N/A | N/A |
| Days Inventory Outstanding (DIO) | 101.6 | 28.2 | 55.0 | N/A | N/A |
| Receivables Turnover | 11.82x | 2.75x | 2.79x | 0.82x | 0.22x |
| Days Sales Outstanding (DSO) | 30.9 | 132.8 | 130.7 | 444.9 | 1660.1 |
| Payables Turnover | 0.49x | N/A | 1.08x | N/A | N/A |
| Days Payable Outstanding (DPO) | 747.3 | N/A | 338.8 | N/A | N/A |
| Cash Conversion Cycle | -614.8 days | 161.0 days | -153.1 days | 444.9 days | 1660.1 days |
| Asset Turnover | 0.36x | 0.78x | 0.67x | 0.03x | 0.04x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 10 | N/A | 250 | 4 | -27 |
| Free Cash Flow (OCF − Capex proxy) | -56 | N/A | 229 | 4 | -12 |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 169.2% | N/A | N/A |
| Dividends Declared | 0 | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |